Showing results (371-380 of 428) with videos related to
Sort By:
Pageof 43
Clinical & Translational Immunology|October 2, 2020
Intratumoral administration of the Toll-like receptor 7/8 agonist 3M-052 enhances interferon-driven tumor immunogenicity and suppresses metastatic spread in preclinical triple-negative breast cancerDamien J Zanker, Alex J Spurling, Natasha K Brockwell, et al.Cancer Immunology, Immunotherapy : CII|June 21, 2015
TLR7 tolerance is independent of the type I IFN pathway and leads to loss of anti-tumor efficacy in miceErina Koga-Yamakawa, Masashi Murata, Simon J Dovedi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2017
Optoacoustic Detection of Early Therapy-Induced Tumor Cell Death Using a Targeted Imaging AgentBangwen Xie, Michal R Tomaszewski, André A Neves, et al.The American Journal of Physiology|May 8, 1999
Metabolic, gastrointestinal, and CNS neuropeptide effects of brain leptin administration in the ratG van Dijk, R J Seeley, T E Thiele, et al.Journal of Cardiac Failure|November 13, 2007
In patients with heart failure elevated soluble TNF-receptor 1 is associated with higher risk of depressionAlec J Moorman, Dariush Mozaffarian, Charles W Wilkinson, et al.Neurology|October 19, 2007
Intranasal insulin improves cognition and modulates beta-amyloid in early ADM A Reger, G S Watson, P S Green, et al.International Journal of Cancer|June 27, 2012
Intratracheal and oral administration of SM-276001: a selective TLR7 agonist, leads to antitumor efficacy in primary and metastatic models of cancerErina Koga-Yamakawa, Simon J Dovedi, Masashi Murata, et al.International Journal of Colorectal Disease|May 3, 2005
Immune responses in advanced colorectal cancer following repeated intradermal vaccination with the anti-CEA murine monoclonal antibody, PR1A3: results of a phase I studyA P Zbar, H Thomas, R W Wilkinson, et al.Archives of General Psychiatry|December 11, 1999
Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucoseS Craft, S Asthana, J W Newcomer, et al.Cancer Research|January 25, 2012
Enhanced apoptosis and tumor growth suppression elicited by combination of MEK (selumetinib) and mTOR kinase inhibitors (AZD8055)Sarah V Holt, Armelle Logie, Barry R Davies, et al.Pageof 43